Summarized by Masters of Longevity from Longevity Docs News.
A look at a telehealth weight‑loss program using GLP‑1 therapy: what the study design and remote care model offer readers considering virtual obesity treatment.
Key Takeaways
- A remote program treating 8,127 women with GLP-1s produced mean 16.1 kg weight loss, equivalent to 15.5% body weight at six months.
- Tirzepatide comprised 99.8% of prescriptions with mean weekly dose 9.5 mg at six months, and 91.4% of participants remained on treatment.
- HbA1c fell by 3.3 mmol/mol and LDL cholesterol fell by 0.61 mmol/L with diabetes and prediabetes categories largely returning to normal ranges.
